Mixed lichenoid and psoriasiform drug eruption induced by rifampicin
Xia Feng, Xin Ye, Jixiang Xu, Changqiang Li
Australasian Journal of Dermatology · 2019-12
Abstract
Rifampicin is an essential first line anti-tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of mixed lichenoid and psoriasiform drug eruption induced by rifampicin.
MeSH terms
- Medicine
- Rifampicin
- Drug eruption
- Dermatology
- Drug
- Drug reaction
- Tuberculosis
- First line
- Ethambutol
- Pharmacology